US4968715A
(en)
*
|
1988-07-06 |
1990-11-06 |
Health Research, Inc. |
Use of purified hematoporphyrin trimers in photodynamic therapy
|
US5002962A
(en)
*
|
1988-07-20 |
1991-03-26 |
Health Research, Inc. |
Photosensitizing agents
|
USRE38994E1
(en)
|
1988-07-20 |
2006-02-28 |
Health Research, Inc. |
Pyropheophorbides conjugates and their use in photodynamic therapy
|
USRE39094E1
(en)
*
|
1988-07-20 |
2006-05-09 |
Health Research, Inc. |
Pyropheophorbides and their use in photodynamic therapy
|
US5198460A
(en)
*
|
1988-07-20 |
1993-03-30 |
Health Research Inc. |
Pyropheophorbides and their use in photodynamic therapy
|
CN1039283C
(zh)
*
|
1988-12-12 |
1998-07-29 |
Fmc公司 |
卟啉的应用
|
US5219878A
(en)
*
|
1990-10-05 |
1993-06-15 |
Queen's University |
Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
|
IL102645A
(en)
*
|
1992-07-26 |
1998-02-22 |
Yeda Res & Dev |
Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
|
US6100392A
(en)
*
|
1992-08-14 |
2000-08-08 |
The Trustees Of The University Of Pennsylavania |
Electron-deficient porphyrins and processes and intermediates for preparing same
|
US5422362A
(en)
*
|
1993-07-29 |
1995-06-06 |
Quadra Logic Technologies, Inc. |
Method to inhibit restenosis
|
US5492924A
(en)
*
|
1993-09-24 |
1996-02-20 |
Fox Chase Cancer Center |
Phorbine derivatives and their use in the diagnosis and therapy of cancer
|
US5591847A
(en)
*
|
1994-05-23 |
1997-01-07 |
Health Research, Inc. |
Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
|
US5882328A
(en)
*
|
1995-01-13 |
1999-03-16 |
Qlt Phototherapeutics, Inc. |
Method to prevent transplant rejection
|
US6316007B1
(en)
*
|
1995-04-04 |
2001-11-13 |
Wound Healing Of Oklahoma |
Combined physical and immunotherapy for cancer
|
CN1090022C
(zh)
*
|
1995-04-04 |
2002-09-04 |
俄克拉荷马创伤治疗所 |
通过光动力疗法与免疫佐剂联合应用治疗癌症
|
AU7237896A
(en)
|
1995-09-06 |
1997-03-27 |
Research Foundation Of The State University Of New York, The |
Two-photon upconverting dyes and applications
|
US5877165A
(en)
*
|
1995-11-02 |
1999-03-02 |
Brookhaven Science Associates |
Boronated porhyrins and methods for their use
|
US5770730A
(en)
*
|
1996-03-08 |
1998-06-23 |
Health Research, Inc. |
Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
|
US5952366A
(en)
*
|
1996-03-08 |
1999-09-14 |
Health Research, Inc. |
Alkyl ether analogs of chlorins having an N-substituted imide ring
|
US6756396B1
(en)
*
|
1997-05-07 |
2004-06-29 |
Qlt Inc. |
Ethylene glycol esters as photoactive agents
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
US6103751A
(en)
*
|
1998-06-22 |
2000-08-15 |
Health Research, Inc. |
Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents
|
WO2000033833A1
(en)
|
1998-12-09 |
2000-06-15 |
Yeda Research And Development Co. Ltd. |
Palladium-substituted bacteriochlorophyll derivatives and use thereof
|
CA2356532A1
(en)
*
|
1999-01-15 |
2000-07-20 |
Light Sciences Corporation |
Noninvasive vascular therapy
|
US6454789B1
(en)
*
|
1999-01-15 |
2002-09-24 |
Light Science Corporation |
Patient portable device for photodynamic therapy
|
US6602274B1
(en)
*
|
1999-01-15 |
2003-08-05 |
Light Sciences Corporation |
Targeted transcutaneous cancer therapy
|
WO2000041725A2
(en)
*
|
1999-01-15 |
2000-07-20 |
Light Sciences Corporation |
Therapeutic compositions for metabolic bone disorders or bone metastases
|
US20040229295A1
(en)
*
|
1999-05-17 |
2004-11-18 |
Marchitto Kevin S. |
Activated delivery of biomolecules using electromagnetic energy
|
US6376483B1
(en)
|
1999-05-27 |
2002-04-23 |
Miravant Pharmaceuticals, Inc. |
Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
|
US6417189B1
(en)
|
1999-11-12 |
2002-07-09 |
Gpi Nil Holdings, Inc. |
AZA compounds, pharmaceutical compositions and methods of use
|
US7045117B2
(en)
*
|
1999-12-01 |
2006-05-16 |
Yeda Research And Development Co. Ltd. |
Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives
|
DE60026568D1
(de)
|
1999-12-21 |
2006-05-04 |
Mgi Gp Inc |
Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
|
US7097826B2
(en)
*
|
1999-12-23 |
2006-08-29 |
Health Research, Inc. |
Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
|
US7897140B2
(en)
*
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
US6534040B2
(en)
|
1999-12-23 |
2003-03-18 |
Health Research, Inc. |
Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
|
US7078014B2
(en)
*
|
1999-12-23 |
2006-07-18 |
Health Research, Inc. |
Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
|
EP1267935A2
(de)
|
2000-01-12 |
2003-01-02 |
Light Sciences Corporation |
Behandlung von augenerkrankungen
|
US6794505B1
(en)
*
|
2000-03-30 |
2004-09-21 |
Miravant Pharmaceuticals, Inc. |
Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
|
US6624187B1
(en)
*
|
2000-06-12 |
2003-09-23 |
Health Research, Inc. |
Long wave length absorbing bacteriochlorin alkyl ether analogs
|
US6462192B2
(en)
|
2001-01-23 |
2002-10-08 |
Miravant Pharmaceuticals, Inc. |
Processes for large scale production of tetrapyrroles
|
WO2002062989A2
(en)
*
|
2001-02-08 |
2002-08-15 |
Sequitur, Inc. |
Methods of light activated release 0f ligands from endosomes
|
US6495585B2
(en)
*
|
2001-03-07 |
2002-12-17 |
Health Research, Inc. |
Method for treating hyperproliferative tissue in a mammal
|
US6894161B2
(en)
*
|
2001-03-27 |
2005-05-17 |
The University Of British Columbia |
Methods and compositions for photo-cross linking photoactive compounds to target tissue
|
RU2183956C1
(ru)
|
2001-03-30 |
2002-06-27 |
Общество с ограниченной ответственностью "РАДА-ФАРМА" |
Фотосенсибилизатор и способ его получения
|
US20030203888A1
(en)
*
|
2001-06-06 |
2003-10-30 |
Boyle Ross William |
Chromophores
|
GB0130778D0
(en)
*
|
2001-12-21 |
2002-02-06 |
Catalyst Biomedica Ltd |
Novel compounds
|
WO2003061696A2
(en)
*
|
2002-01-23 |
2003-07-31 |
Light Sciences Corporation |
Systems and methods for photodynamic therapy
|
US6846311B2
(en)
*
|
2002-04-02 |
2005-01-25 |
Acueity, Inc. |
Method and apparatus for in VIVO treatment of mammary ducts by light induced fluorescence
|
WO2004002476A2
(en)
|
2002-06-27 |
2004-01-08 |
Health Research, Inc. |
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
|
WO2004005289A2
(en)
*
|
2002-07-02 |
2004-01-15 |
Health Research, Inc. |
Efficient synthesis of pyropheophorbide a and its derivatives
|
WO2004080284A2
(en)
*
|
2003-03-07 |
2004-09-23 |
Board Of Regents, The University Of Texas System |
Antibody-targeted photodynamic therapy
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
EP1541091A1
(de)
*
|
2003-12-10 |
2005-06-15 |
EL.EN. S.p.A. |
Vorrichtung zur Tumorbehandlung mittels Laser-Thermotherapie
|
CA2553381C
(en)
|
2004-01-20 |
2011-03-22 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US8512738B2
(en)
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
EP2216026B1
(de)
*
|
2004-07-12 |
2016-04-20 |
Allergan, Inc. |
Ophthalmologische Zusammensetzungen und deren Verwendung zur Behandlung von Augenkrankheiten
|
CN1984915B
(zh)
*
|
2004-07-16 |
2012-12-19 |
健康研究有限公司 |
荧光染料和肿瘤亲和的四吡咯的加合物
|
US20060052286A1
(en)
*
|
2004-08-13 |
2006-03-09 |
Yale University |
Factor VII conjugates for selectively treating neovascularization disorders
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20060223750A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Allergan, Inc. |
Agents and methods for enhancing photodynamic therapy
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
US20100137396A1
(en)
*
|
2007-01-09 |
2010-06-03 |
Health Research, Inc |
Treatment of esophageal high grade dysplasia using photodynamic therapy
|
US20100144820A1
(en)
*
|
2007-01-09 |
2010-06-10 |
Health Research, Inc. |
Therapeutic hpph dosage for pdt
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
KR100912446B1
(ko)
|
2007-09-12 |
2009-08-14 |
인제대학교 산학협력단 |
항암활성을 가지는 클로린 유도체
|
JP2010539163A
(ja)
*
|
2007-09-14 |
2010-12-16 |
ヘルス リサーチ インコーポレイテッド |
腫瘍イメージング及び治療用のマルチモーダル剤
|
US20100056983A1
(en)
*
|
2007-09-27 |
2010-03-04 |
Health Research, Inc. |
Treatment of cancer using photodynamic therapy
|
RU2367434C1
(ru)
*
|
2008-04-22 |
2009-09-20 |
Виктор Александрович Борисов |
Фотосенсибилизатор и способ его получения
|
US8829020B2
(en)
|
2009-07-16 |
2014-09-09 |
Mallinckrodt Llc |
Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
|
CN102724951A
(zh)
|
2009-11-09 |
2012-10-10 |
阿勒根公司 |
用于刺激毛发生长的组合物和方法
|
US8609837B2
(en)
|
2010-07-06 |
2013-12-17 |
Health Research, Inc. |
Metallation enhancements in tumor-imaging and PDT therapy
|
US11773188B2
(en)
|
2012-01-20 |
2023-10-03 |
Immunophotonics, Inc |
Chitosan-derived compositions
|
RS61257B1
(sr)
|
2012-01-20 |
2021-01-29 |
Immunophotonics Inc |
Jedinjenja izvedena iz hitozana
|
CN103705532B
(zh)
|
2012-10-08 |
2016-09-14 |
浙江海正药业股份有限公司 |
靶向胸苷激酶光敏剂及其药物组合物与治疗癌症的用途
|
US9642916B2
(en)
*
|
2012-12-12 |
2017-05-09 |
The Regents Of The University Of California |
Porphyrin modified telodendrimers
|
DK2931728T3
(da)
*
|
2012-12-14 |
2020-05-11 |
Rmw Cho Group Ltd |
Chlorinderivat, der er nyttigt ved fotodynamisk terapi og diagnose
|
EP2956096A1
(de)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Implantat mit langzeit-wirkstofffreisetzung
|
EP2967056B1
(de)
|
2013-03-15 |
2018-02-21 |
Suncor Energy Inc. |
Herbizidzusammensetzungen
|
CN104086554B
(zh)
*
|
2014-05-30 |
2016-02-17 |
桂林晖昂生化药业有限责任公司 |
一种新型的完全水溶的光敏剂单体及其制备方法及应用
|
US20190002594A1
(en)
|
2014-07-16 |
2019-01-03 |
Immunophotonics, Inc. |
Chitosan-Derived Compositions
|
US10035806B2
(en)
|
2015-10-06 |
2018-07-31 |
California Institute Of Technology |
Derivatized corroles and metallocorroles and their use as imaging and therapeutic agents
|
WO2018053316A1
(en)
|
2016-09-15 |
2018-03-22 |
The Regents Of The University Of California |
Improved hybrid telodendrimers
|
CA3047105A1
(en)
*
|
2016-12-13 |
2018-06-21 |
Health Research, Inc. |
Epidermal growth factor receptor (egfr) targeted photosensitizers
|
US11872194B2
(en)
|
2017-03-14 |
2024-01-16 |
Ohio State Innovation Foundation |
Methods and compositions related to a tissue factor-targeting IGG3 immunoconjugates
|
CN112028898B
(zh)
*
|
2019-06-04 |
2023-06-23 |
康宏耀源(天津)科技有限公司 |
不同连接链偶联的叶酸靶向卟吩类光敏剂及其合成和应用
|
CN113461697B
(zh)
|
2021-06-29 |
2023-03-10 |
西南交通大学 |
一种二氢卟吩类化合物及其制备方法和用途
|